$BDPT
BIOADAPTIVES, INC.
CIK:0001575142|SEC Filings
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) | ||||
| Revenues | $ 4,988 | $ 3,219 | $ 10,502 | $ 3,219 |
| Cost of revenue | 748 | 2,156 | 2,149 | 2,156 |
| Gross Profit | 4,240 | 1,063 | 8,353 | 1,063 |
| Operating Expenses | ||||
| General and administrative | 177,745 | 197,892 | 358,795 | 341,275 |
| Professional fees | 22,171 | 81,390 | 41,952 | 187,155 |
| Impairment of inventory | 0 | 0 | 0 | 0 |
| Depreciation | 1,500 | 1,000 | 3,000 | 1,000 |
| Total Operating Expenses | 201,416 | 280,282 | 403,747 | 529,430 |
| Loss from operations | (197,176) | (279,219) | (395,394) | (528,367) |
| Other Income (Expense) | ||||
| Other income | 0 | 0 | 5 | 0 |
| Interest expense | (115,038) | (9,649) | (202,795) | (19,296) |
| Change in fair value of derivative liabilities | 446,730 | 130,954 | 621,614 | 192,613 |
| Gain on settlement of debt | 15,574 | 0 | 15,574 | 0 |
| Total Other Income | 347,266 | 121,305 | 434,398 | 173,317 |
| Income (loss) before income taxes | 150,090 | (157,914) | 39,004 | (355,050) |
| Net Income (Loss) | $ 150,090 | $ (157,914) | $ 39,004 | $ (355,050) |
| Net Income (Loss) Per Common Share: | ||||
| Basic | $ 0.01 | $ (0.02) | $ 0.00 | $ (0.04) |
| Diluted | $ (0.00) | $ (0.02) | $ (0.00) | $ (0.04) |
| Weighted Average Number of Common Shares Outstanding: | ||||
| Basic and Diluted | 14,192,536 | 9,533,375 | 13,106,785 | 8,998,067 |